Manchester Researchers Discover Half Of All Adults With Cystic Fibrosis Affected By Airborne Fungus

Experts believe a pioneering breakthrough by a Manchester hospital research team could pave the way for doctors to better understand and treat adults with Cystic Fibrosis (CF), helping them live longer and healthier lives. http://www.medicalnewstoday.com/releases/262897.php Continue reading Manchester Researchers Discover Half Of All Adults With Cystic Fibrosis Affected By Airborne Fungus

Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test

Journal of Cystic Fibrosis, 06/28/2013  Clinical Article

Schmid K et al. – An annual oral glucose tolerance test (OGTT) has become part of standard care in cystic fibrosis (CF) to screen for CF–related diabetes (CFRD). The objective of this study was to determine predictors for future CFRD derived from an OGTT. In this large study, IFT, IGT, and Continue reading Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test

Cystic Fibrosis Genes & Gene Therapy–June 29th 13:00 (BST)

The latest cystic fibrosis research summarized by the study authors.  
No spin, no headlines. 
More added daily.
 cfunite.org/research

The next live CFUnite event, with added opportunities for interaction, will discuss the genes and genetics of cystic fibrosis.  What does dF508, G551D and all the other numbers actually mean? Continue reading Cystic Fibrosis Genes & Gene Therapy–June 29th 13:00 (BST)

For new Rhode Island firm, peptides hold hope for disease-altering cystic fibrosis treatments

It’s been nearly two and a half decades since the gene associated with the inherited disease cystic fibrosis was discovered, paving the way for disease-modifying drugs. In that time, only one such drug has been approved in the U.S. and Europe – Vertex’s Kalydeco. And that drug is only Continue reading For new Rhode Island firm, peptides hold hope for disease-altering cystic fibrosis treatments

Cystic Fibrosis: New Assay May Help Individualize Care

A rapid and quantitative assay for assessing function of the CFTR gene using intestinal organoids has been developed, according to a study conducted by Johanna F. Dekkers, MS, from the University Medical Center in Utrecht, the Netherlands, and colleagues. Continue reading Cystic Fibrosis: New Assay May Help Individualize Care

Proteostasis Therapeutics Presents Preclinical Data on Parkinson’s Disease and Cystic Fibrosis Targets at EMBO Conference

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, today presented data on the Company’s preclinical targets for Parkinson’s disease and cystic fibrosis at a Continue reading Proteostasis Therapeutics Presents Preclinical Data on Parkinson’s Disease and Cystic Fibrosis Targets at EMBO Conference

U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios’ Novel Biologic Candidate for Pseudomonas aeruginosa

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), and KaloBios Pharmaceuticals (KBIO) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Sanofi Pasteur for the investigation of KB001A, an Continue reading U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios’ Novel Biologic Candidate for Pseudomonas aeruginosa